MEPOLIZUMAB

Clinical Indication

For maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils

Comments

In line with NICE TA1166

Funding from 15th September 2026

Date of classification

July 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.